Mig Pediatric (Ibuprofen)

Ibuprofen, the active ingredient in Mig Pediatric, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for pediatric use. It is used to relieve pain, reduce fever, and lessen inflammation in children. GNH USA supplies Mig Pediatric as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts systemically to manage common childhood complaints related to pain, fever, and inflammation. - Pain: provides relief from mild to moderate acute pain such as headache or toothache. - Fever: lowers elevated body temperature associated with infections or immunizations. - Inflammation: reduces swelling and discomfort in conditions like minor sprains or musculoskeletal strain.

Adverse reactions may occur with ibuprofen use and are categorized by frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Rash or mild skin irritation.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Renal impairment or decreased urine output. - Severe allergic reactions: anaphylaxis, angioedema. - Hepatotoxicity: elevated liver enzymes. - Blood disorders: thrombocytopenia or leukopenia.

Before using Mig Pediatric, consider the following safety measures. - Age Restriction: intended for pediatric patients as directed by a healthcare professional. - Gastrointestinal Risk: avoid use in children with active ulcers or severe GI disorders. - Renal Function: use cautiously in patients with impaired kidney function. - Concomitant Medications: review other NSAIDs or anticoagulants with a clinician. - Allergy Check: discontinue if signs of hypersensitivity appear. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Ibuprofen can affect the activity of several other medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - High‑dose aspirin: heightened gastrointestinal toxicity. - Certain antihypertensives (e.g., ACE inhibitors, diuretics): may reduce blood pressure control.

Moderate Interactions (Monitor Closely): - Other NSAIDs or COX‑2 inhibitors: additive renal and GI effects. - Lithium: possible increase in serum lithium levels. - Methotrexate: may elevate methotrexate toxicity. - Corticosteroids: enhanced risk of ulceration. - Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding tendency.